Cancer Research

Is Ziihera a Game-Changer for HER2-Positive Biliary Cancer?
Management & Regulatory Is Ziihera a Game-Changer for HER2-Positive Biliary Cancer?

Introducing Ivan Kairatov, a biopharma expert renowned for his insights into pharmaceutical technology and innovation, particularly in research and development. Today, we're delving into a groundbreaking moment for biliary tract cancer treatment with the conditional approval of Jazz

Planned C-Sections Linked to Increased Risk of Childhood Leukemia
Research & Development Planned C-Sections Linked to Increased Risk of Childhood Leukemia

A new study centered around planned cesarean sections (C-sections) and their association with childhood leukemia sparks significant discussions. With rising rates of elective C-sections globally, healthcare professionals and policymakers are intrigued by findings suggesting heightened risks for

Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer
Research & Development Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer

In this engaging conversation with biopharma expert Ivan Kairatov, we delve into the complexities and innovations in treating brain metastases from ovarian cancer. Ivan shares insights from a recent study that evaluated the effectiveness of Gamma Knife Stereotactic Radiosurgery (GKSRS) in managing

Are Tailored Cancer Treatments the Future of Oncology?
Research & Development Are Tailored Cancer Treatments the Future of Oncology?

The landscape of cancer treatment has undergone a dynamic transformation, propelling the field towards more personalized methodologies aimed at improving patient outcomes. This evolution is largely informed by the recognition that cancer is not a monolithic disease but a complex network of

Is Genetic Insight Key to Early Ovarian Cancer Detection?
Research & Development Is Genetic Insight Key to Early Ovarian Cancer Detection?

Ovarian cancer remains a formidable challenge in the medical community due to its elusive nature and high fatality rate. With approximately 75% of cases detected at later stages, patients often face dire prognoses. Current diagnostic methods are largely insufficient, typically identifying the

Kinsley Crushes Cancer: Hope and Unity in Pediatric Fight
Research & Development Kinsley Crushes Cancer: Hope and Unity in Pediatric Fight

The journey of young Kinsley McLamore, a spirited 4-year-old facing a formidable battle against acute lymphoblastic leukemia, showcases a commendable blend of resilience, advocacy, and community support. Diagnosed on March 21, 2024, Kinsley is now navigating through the maintenance stage of a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later